NEOGENOMICS INC Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Neogenomics Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q3 2024.
  • Neogenomics Inc Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $81.4M, a 6.53% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $81.4M -$5.69M -6.53% Sep 30, 2024 10-Q 2024-11-05
Q2 2024 $83.7M -$7.74M -8.47% Jun 30, 2024 10-Q 2024-07-30
Q1 2024 $86.6M -$7.21M -7.68% Mar 31, 2024 10-Q 2024-04-30
Q4 2023 $91.8M -$4.34M -4.52% Dec 31, 2023 10-Q 2024-11-05
Q3 2023 $87.1M -$11.8M -11.9% Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $91.4M -$8.51M -8.51% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $93.8M -$8.17M -8.01% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $96.1M -$6.09M -5.96% Dec 31, 2022 10-K 2024-02-20
Q3 2022 $98.9M -$3.37M -3.29% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $99.9M +$45.4M +83.1% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $102M +$51.1M +100% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $102M +$56.4M +123% Dec 31, 2021 10-K 2023-02-24
Q3 2021 $102M +$56.5M +123% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $54.6M +$7M +14.7% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $50.9M +$1.82M +3.71% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $45.8M +$19.3M +72.8% Dec 31, 2020 10-K 2022-02-25
Q3 2020 $45.9M +$20.1M +77.8% Sep 30, 2020 10-Q 2020-10-29
Q2 2020 $47.6M +$21.5M +82.5% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 $49.1M +$29.4M +149% Mar 31, 2020 10-Q 2020-04-29
Q4 2019 $26.5M +$16.8M +173% Dec 31, 2019 10-K 2021-02-25
Q3 2019 $25.8M Sep 30, 2019 10-Q 2019-11-13
Q2 2019 $26.1M Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $19.7M Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $9.7M Jan 1, 2019 10-K 2020-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.